Last Posted: Jan 16, 2020
- Metabolomic profiling of dried blood spots reveals gender-specific discriminant models for the diagnosis of small cell lung cancer.
Yu Li et al. Aging 2020 Jan 12 - Use of biomarker testing in lung cancer among Puerto Rico and Florida Physicians: Results of a comparative study.
Muñoz-Antonia Teresita et al. Journal of clinical pathways : the foundation of value-based care 2019 Oct 5(8) 33-40 - Clinical applications of liquid biopsies for early lung cancer detection.
Zheng Hao et al. American journal of cancer research 2019 9(12) 2567-2579 - Molecular diagnostic characteristics based on the next generation sequencing in lung cancer and its relationship with the expression of PD-L1.
Liu Junying et al. Pathology, research and practice 2019 Dec 152797 - [Investigation on the Possibility of EGFR Mutation Testing on DNA Extracted from Fixation Liquid of Lung Cancer Biopsy].
Liao Xuanzhi et al. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2019 Jul 22(7) 433-439 - Compliance to regional recommendations for molecular analyses and management of advanced lung cancer patients.
Swalduz Aurélie et al. Future oncology (London, England) 2019 Jun 15(18) 2139-2149 - Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients.
Papadopoulou Eirini et al. PloS one 2019 14(12) e0226853 - Rapid clinical mutational testing of KRAS , BRAF and EGFR : a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencing.
Van Haele Matthias et al. Journal of clinical pathology 2020 Jan 73(1) 35-41 - A Deep Learning Method for Producing Ventilation Images from 4DCT: First Comparison with Technegas SPECT Ventilation.
Liu Zhiqiang et al. Medical physics 2019 Dec - A Six-Gene Signature Predicts Survival of Adenocarcinoma Type of Non-Small-Cell Lung Cancer Patients: A Comprehensive Study Based on Integrated Analysis and Weighted Gene Coexpression Network.
Xie Hui et al. BioMed research international 2019 20194250613
No hay comentarios:
Publicar un comentario